{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:41:16Z","timestamp":1790523676721,"version":"4.1.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T00:00:00Z","timestamp":1462752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005689","name":"G\u00f6teborgs L\u00e4kares\u00e4llskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gustav V 80 year foundation"},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002706","name":"AFA F\u00f6rs\u00e4kring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003849","name":"IngaBritt och Arne Lundbergs Forskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154630","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T17:28:49Z","timestamp":1462814929000},"page":"e0154630","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis"],"prefix":"10.1371","volume":"11","author":[{"given":"Sara","family":"Tengvall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Eneljung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Jirholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kihlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga-Lill","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Henningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenth","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Gjertsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrrheum.2014.123","article-title":"Adverse reactions to biologic agents and their medical management","volume":"10","author":"O Boyman","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.berh.2010.01.007","article-title":"Treating to re-establish tolerance in inflammatory arthritis\u2014lessons from other diseases","volume":"24","author":"FA Cooles","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2567.1998.00637.x","article-title":"Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA\/1 mice","volume":"95","author":"LK Myers","year":"1998","journal-title":"Immunology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/eji.1830220722","article-title":"Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection","volume":"22","author":"E Michaelsson","year":"1992","journal-title":"Eur J Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/eji.1830240736","article-title":"Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis","volume":"24","author":"U Brunsberg","year":"1994","journal-title":"Eur J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1073\/pnas.83.19.7443","article-title":"Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen","volume":"83","author":"C Nagler-Anderson","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.4049\/jimmunol.155.7.3653","article-title":"Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis","volume":"155","author":"SD Khare","year":"1995","journal-title":"J Immunol"},{"key":"ref8","article-title":"Oral administration of type-II collagen peptide 250\u2013270 suppresses specific cellular and humoral immune response in collagen-induced arthritis","author":"P Zhu","year":"2006","journal-title":"Clin Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0008-8749(88)90169-4","article-title":"Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis","volume":"115","author":"RF van Vollenhoven","year":"1988","journal-title":"Cell Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2249.1997.3721269.x","article-title":"Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; distinct tolerogenic property of the conjugated collagen from the native one","volume":"108","author":"HO Ito","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/jaut.1998.0255","article-title":"Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis","volume":"12","author":"CQ Chu","year":"1999","journal-title":"J Autoimmun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/art.24566","article-title":"Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis","volume":"60","author":"A Hasselberg","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.180.2.745","article-title":"T cell recognition of carbohydrates on type II collagen","volume":"180","author":"E Michaelsson","year":"1994","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4049\/jimmunol.176.3.1525","article-title":"Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules","volume":"176","author":"B Dzhambazov","year":"2006","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1002\/art.10687","article-title":"Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice","volume":"46","author":"LK Myers","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/80525","article-title":"Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group","volume":"6","author":"L Kappos","year":"2000","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0167-0115(90)90194-2","article-title":"Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney","volume":"31","author":"A Kervran","year":"1990","journal-title":"Regul Pept"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/ar1169","article-title":"Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen","volume":"6","author":"SY Min","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e40356","DOI":"10.1371\/journal.pone.0040356","article-title":"Helminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collagen-induced arthritis through Foxp3+ regulatory T cells","volume":"7","author":"F Carranza","year":"2012","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2567.2008.02875.x","article-title":"Falgarone G Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo","volume":"126","author":"O Jaen","year":"2009","journal-title":"Immunology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cellimm.2012.06.009","article-title":"A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis","volume":"278","author":"MJ Park","year":"2012","journal-title":"Cell Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e0131152","DOI":"10.1371\/journal.pone.0131152","article-title":"Antigen-Specific Tolerogenic Dendritic Cells Ameliorate the Severity of Murine Collagen-Induced Arthritis","volume":"10","author":"B Ning","year":"2015","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4049\/jimmunol.179.2.1369","article-title":"B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity","volume":"179","author":"K Yanaba","year":"2007","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood-2011-02-336115","article-title":"Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion","volume":"118","author":"S Morlacchi","year":"2011","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.4049\/jimmunol.159.10.5032","article-title":"Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody","volume":"159","author":"C Mauri","year":"1997","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"C Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"JG Evans","year":"2007","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar3736","article-title":"Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis","volume":"14","author":"NA Carter","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.170.3.1383","article-title":"Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses","volume":"170","author":"Y Ding","year":"2003","journal-title":"Journal of immunology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/ATVBAHA.110.207464","article-title":"Suppressors of cytokine signaling (SOCS) proteins and JAK\/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3","volume":"31","author":"T Tamiya","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/eji.201344369","article-title":"SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications","volume":"44","author":"Y Liang","year":"2014","journal-title":"Eur J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2009.06.010","article-title":"A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 mice","volume":"133","author":"A Sharabi","year":"2009","journal-title":"Clin Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1136\/ard.2011.154815","article-title":"A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis","volume":"70","author":"S Veenbergen","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e49731","DOI":"10.1371\/journal.pone.0049731","article-title":"Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice","volume":"7","author":"L Henningsson","year":"2012","journal-title":"PloS one"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses","volume":"142","author":"LF Lu","year":"2010","journal-title":"Cell"},{"key":"ref36","first-page":"469","article-title":"Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells","volume":"4","author":"J Larkin 3rd","year":"2013","journal-title":"Front Immunol"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/mt.2009.299","article-title":"Tolerance Induction Using Lentiviral Gene Delivery Delays Onset and Severity of Collagen II Arthritis","volume":"17","author":"I Gjertsson","year":"2009","journal-title":"Mol Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"345092","DOI":"10.1155\/2013\/345092","article-title":"Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis","volume":"2013","author":"T Eneljung","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nri1416","article-title":"Seventeen-colour flow cytometry: unravelling the immune system","volume":"4","author":"SP Perfetto","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X","article-title":"Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis","volume":"28","author":"A Corthay","year":"1998","journal-title":"Eur J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2249.1993.tb08218.x","article-title":"Genes on the X chromosome affect development of collagen-induced arthritis in mice","volume":"94","author":"L Jansson","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.23049","article-title":"Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation","volume":"58","author":"KS Nandakumar","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"ME Morgan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"19078","DOI":"10.1073\/pnas.0907396106","article-title":"Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis","volume":"106","author":"GP Wright","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2007.086066","article-title":"Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis","volume":"68","author":"H Kelchtermans","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-003-0127-1","article-title":"Immunopathogenesis of collagen arthritis","volume":"25","author":"DD Brand","year":"2003","journal-title":"Springer Semin Immunopathol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clim.2009.03.522","article-title":"Breaking old paradigms: Th17 cells in autoimmune arthritis","volume":"132","author":"A Peck","year":"2009","journal-title":"Clin Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"S Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"S Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/470468","article-title":"SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases","volume":"2010","author":"M Fujimoto","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1084\/jem.20110428","article-title":"SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production","volume":"208","author":"R Takahashi","year":"2011","journal-title":"J Exp Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-6143.2008.02479.x","article-title":"Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation","volume":"9","author":"VA Huurman","year":"2009","journal-title":"Am J Transplant"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta","volume":"204","author":"S Nadkarni","year":"2007","journal-title":"J Exp Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/eji.200425637","article-title":"The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans","volume":"35","author":"B Dzhambazov","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.25036","article-title":"Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients","volume":"62","author":"O Snir","journal-title":"Arthritis Rheum"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"N Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood-2004-11-4547","article-title":"B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model","volume":"106","author":"K Dunussi-Joannopoulos","year":"2005","journal-title":"Blood"},{"key":"ref58","article-title":"The expanding family of regulatory B cells","author":"C Mauri","year":"2015","journal-title":"Int Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaut.2011.05.002","article-title":"To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice","volume":"37","author":"M Behrens","year":"2011","journal-title":"J Autoimmun"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"SZ Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cytogfr.2011.11.003","article-title":"Collagen-induced arthritis and related animal models: how much of their pathogenesis is auto-immune, how much is auto-inflammatory?","volume":"22","author":"A Billiau","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","article-title":"Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers","volume":"37","author":"SK Lee","year":"2012","journal-title":"Immunity"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/156652412800620057","article-title":"Bagot M IL-10 producing regulatory B cells in mice and humans: state of the art","volume":"12","author":"JD Bouaziz","year":"2012","journal-title":"Curr Mol Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T04:27:24Z","timestamp":1692332844000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154630"}},"subtitle":[],"editor":[{"given":"Song Guo","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,9]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154630","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,9]]}}}